2 Insights on

• Increased Fecal Bile Acid Levels
• Increased Lead Excretion

4 Insights on

• Improved Gastrointestinal Health
• Increased Helicobacter pylori Eradication Rate
• Reduced Symptoms of Lactose Malabsorption
• Improved Lactose Malabsorption

4 Insights on

• Reduced Inflammation Levels
• Modulated Gut Microbiota
• Maintained Mucosal Barrier Integrity
• Increased Beneficial Gut Microbiota Abundance

2 Insights on

• Increased Antioxidant Activity
• Improved Overall Health

2 Insights on

• Reduced Uremic Toxins Levels
• Reduced Mucosal Pro-Inflammatory Activity

7 Insights on

• Reduced Interleukin-6 Levels
• Reduced Inflammatory Markers
• Reduced Inflammation Levels
• Reduced Soluble VCAM-1 Levels
• Increased Proportion of Verrucomicrobia in Gastrointestinal Microbiome
• Modification of Gastrointestinal Microbiome
• Altered Gastrointestinal Microbiome Composition

4 Insights on

• Reduced Survival Rate
• Reduced BCG Phagocytic Intake
• No Significant Change in BCG Phagocytic Intake
• Reduced Mycobacterium bovis BCG Phagocytic Uptake

5 Insights on

• Improved Skin Hydration
• Enhanced Interferon Gamma Production
• Improved Skin Moisture Retention
• Increased Hyaluronic Acid Production
• Increased Hyaluronic Acid Synthesis in Fibroblasts

4 Insights on

• Increased Short-Chain Fatty Acid Levels
• Improved Fecal Microbiota Diversity
• Reduced Hypersensitivity Responses
• Improved Allergic Inflammation Markers

4 Insights on

• Improved Mycological Cure Rate
• Reduced Treatment Duration
• Absence of Severe Adverse Events
• Improved Mycological Cure Rate of Oral Candidiasis

3 Insights on

• Reduced Risk of Necrotizing Enterocolitis
• Reduced Allergic Diseases
• Promotion of Healthy Gut Microbial Colonization

16 Insights on

• Improved Gut Microbiota Diversity
• Increased Body Weight
• Improved Growth Performance
• Improved Weight Gain
• Improved Functional Genes in Intestinal Microbiota
• Enhanced Metabolic Pathway Function
• Reduced Metabolic Functions of Intestinal Microbiota
• Improved Microflora Composition
• Enhanced Gut Microbiota Diversity
• Improved Metabolic Pathway Functions in Intestinal Microbiota
• Improved Intestinal Microflora
• Increased Functional Gene Abundance in Small Intestine
• Enhanced Small Intestine Metabolic Function
• Enhanced Functional Gene Presence in Small Intestine
• Improved Gut Microbiota Composition in Small Intestine
• Enhanced Metabolism in Small Intestine Microbiota

2 Insights on

• Reduced Pro-inflammatory Cytokine Levels
• Unchanged IFN-γ Levels

10 Insights on

• Reduced Incidence of Adverse Events
• Reduced Duration of Diarrhea
• Reduced Stool Frequency
• Reduced Incidence of Loose Stools
• Resolution of Diarrhea
• Reduced Mean Number of Stools per Day
• Improved Therapy Acceptability
• Reduced Proportion of Patients with Loose Stools
• Good Safety Profile with Low Adverse Event Rate
• High Treatment Acceptability

6 Insights on

• Improved Immune Response
• Increased Anti-Inflammatory Levels
• Reduced Nasal Mucosa Neutrophil Infiltration
• Improved Airway Immune Response
• Modulated Systemic Immune Response
• Modulated Upper Airway Immune Response

5 Insights on

• Increased Antioxidant Activity
• Reduced Inflammation Levels
• Enhanced Antimicrobial Resistance
• Increased Antimicrobial Resistance
• Increased Anti-Tumor Activity

1 Insight on

• Reduced Crying Duration

5 Insights on

• Increased Body Weight
• Improved Intestinal Morphology
• Reduced Serum Inflammatory Factors
• Enhanced Colon Bacterial Diversity
• Enhanced Abundance of Beneficial Bacterial Species

1 Insight on

• Reduced Intestinal Inflammation

16 Insights on

• Reduced Antibiotic-Associated Diarrhea
• Reduced Ulcerative Colitis Symptoms
• Reduced Colitis Symptoms
• Improved Intestinal Function
• Relieved Constipation
• Reduced Constipation
• Improved Irritable Bowel Syndrome Symptoms
• Improved Management of Acute Diarrhoea
• Improved Management of Antibiotic-Related Diarrhea
• Improved Constipation Management
• Improved Management of Colitis
• No Mutagenicity, Teratogenicity, or Genotoxicity
• No Mutagenic Effects
• Reduced Acute Diarrhea Incidence
• Reduced Irritable Bowel Syndrome Symptoms
• Reduced Antibiotic-Related Diarrhea

2 Insights on

• Reduced Gastrointestinal Symptoms
• Improved Stool Formation

3 Insights on

• Increased Acyl Ghrelin Secretion
• Increased Appetite
• Increased Acyl/Des-Acyl Ghrelin Ratio

2 Insights on

• Improved Gastrointestinal Symptoms
• Improved Stool Formation

3 Insights on

• Reduced Joint Swelling
• Reduced Frequency of Disturbed Sleep
• Reduced Sick Leave Days

2 Insights on

• Increased Short-Term Food Intake
• Increased Acyl Ghrelin Secretion

2 Insights on

• Reduced Gastrointestinal Symptoms
• Improved Stool Formation

2 Insights on

• Improved Gut Microbiota Composition
• Improved Intestinal Barrier Function

1 Insight on

• MRD Negativity in Multiple Myeloma

6 Insights on

• Increased Antioxidant Activity
• Enhanced Immune Function
• Reduced Inflammation
• Reduced Angiotensin I-Converting Enzyme Activity
• Increased Immune Function
• Improved Neuroprotection

4 Insights on

• Improved Gut Microbiota Diversity
• Reduced Body Weight
• Increased Adiponectin Levels
• Reduced Blood Leptin Levels